CPT1B and cardiovascular disorder: Previous research has demonstrated that l-carnitine treatment augments FAO and CPTI expression, furthermore l-carnitine supplementation might be an effective tool for improvement of glucose utilization in TIIDM [31], which is important in the pathogenesis of multiple cardiovascular disorders [32].